Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Howard

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Canadian Medical Association Journal|March 24, 2010
THE TREATMENT OF LOBAR PNEUMONIAC P Howard, C W Fullerton
Canadian Medical Association Journal|March 24, 2010
An Address on Acute Articular Rheumatism and Other Members of the Rheumatic CycleC P Howard, E S Mills
Canadian Medical Association Journal|March 24, 2010
A STUDY OF CANCER OF THE STOMACHC P Howard, C W Fullerton
Clinical Chemistry|May 1, 1984
Visual detection of abnormal hemoglobin with a procedure for glycated hemoglobinC P Howard, N A Reddig, K Meek
Mayo Clinic Proceedings|June 1, 1977
Feminizing adrenal adenoma in a boy. Case report and literature reviewC P Howard, H Takahashi, A B Hayles
American Journal of Diseases of Children (1960)|October 1, 1983
Eikenella corrodens as a cause of thyroid abscessP Vichyanond, C P Howard, L C Olson
American Journal of Diseases of Children (1960)|April 1, 1981
Children with growth hormone deficiency. Intermittent treatment with somatropin and oxandroloneC P Howard, H Takahashi, A B Hayles
Acta Endocrinologica|June 1, 1984
Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarismJ A Grunt, C P Howard, W H Daughaday
Diabetes, Obesity & Metabolism|June 26, 2012
Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trialA Rissanen, C P Howard, J Botha, et al.
Diabetes & Metabolism|October 1, 2013
Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trialJ Hensen, C P Howard, V Walter, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Canadian Medical Association Journal|March 24, 2010
THE TREATMENT OF LOBAR PNEUMONIAC P Howard, C W Fullerton
Canadian Medical Association Journal|March 24, 2010
An Address on Acute Articular Rheumatism and Other Members of the Rheumatic CycleC P Howard, E S Mills
Canadian Medical Association Journal|March 24, 2010
A STUDY OF CANCER OF THE STOMACHC P Howard, C W Fullerton
Clinical Chemistry|May 1, 1984
Visual detection of abnormal hemoglobin with a procedure for glycated hemoglobinC P Howard, N A Reddig, K Meek
Mayo Clinic Proceedings|June 1, 1977
Feminizing adrenal adenoma in a boy. Case report and literature reviewC P Howard, H Takahashi, A B Hayles
American Journal of Diseases of Children (1960)|October 1, 1983
Eikenella corrodens as a cause of thyroid abscessP Vichyanond, C P Howard, L C Olson
American Journal of Diseases of Children (1960)|April 1, 1981
Children with growth hormone deficiency. Intermittent treatment with somatropin and oxandroloneC P Howard, H Takahashi, A B Hayles
Acta Endocrinologica|June 1, 1984
Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarismJ A Grunt, C P Howard, W H Daughaday
Diabetes, Obesity & Metabolism|June 26, 2012
Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trialA Rissanen, C P Howard, J Botha, et al.
Diabetes & Metabolism|October 1, 2013
Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trialJ Hensen, C P Howard, V Walter, et al.
Pageof 4